{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:38:27Z","timestamp":1792715907237,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM057226"],"award-info":[{"award-number":["R01GM057226"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM089807"],"award-info":[{"award-number":["R01GM089807"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bbi.2014.07.010","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T20:46:30Z","timestamp":1406061990000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation"],"prefix":"10.1016","volume":"44","author":[{"given":"Mauricio","family":"Rosas-Ballina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio I.","family":"Vald\u00e9s-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"Dancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendar","family":"Ochani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peder S.","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta S.","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Al-Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin A.","family":"Pavlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2014.07.010_b0005","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20120571","article-title":"Neural reflexes in inflammation and immunity","volume":"209","author":"Andersson","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0889-1591(89)90029-9","article-title":"Origin of noradrenergic innervation of the spleen in rats","volume":"3","author":"Bellinger","year":"1989","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.07.010_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0165-1838(93)90046-W","article-title":"Characterization of vagal innervation to the rat celiac, suprarenal and mesenteric ganglia","volume":"42","author":"Berthoud","year":"1993","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.bbi.2014.07.010_b0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","article-title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","volume":"54","author":"Bodick","year":"1997","journal-title":"Arch. Neurol."},{"issue":"Suppl. 4","key":"10.1016\/j.bbi.2014.07.010_b0025","first-page":"S16","article-title":"The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease","volume":"11","author":"Bodick","year":"1997","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bbi.2014.07.010_b0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2014.07.010_b0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbi.2014.07.010_b0040","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0026-895X(24)13285-3","article-title":"On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor","volume":"53","author":"Christopoulos","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbi.2014.07.010_b0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0304-3940(80)90047-6","article-title":"Standardization of the sucrose-potassium phosphate-glyoxylic acid histofluorescence method for tissue monoamines","volume":"17","author":"de la Torre","year":"1980","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2014.07.010_b0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI40645","article-title":"Comprehensive assessment of chemokine expression profiles by flow cytometry","volume":"120","author":"Eberlein","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2014.07.010_b0055","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.145.11.3762","article-title":"Requirement of endogenous tumor necrosis factor\/cachectin for recovery from experimental peritonitis","volume":"145","author":"Echtenacher","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2014.07.010_b0060","first-page":"85","article-title":"Cellular and molecular mechanisms of TNF protection in septic peritonitis","volume":"47","author":"Echtenacher","year":"1995","journal-title":"J. Inflamm."},{"key":"10.1016\/j.bbi.2014.07.010_b0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/09680519020080051001","article-title":"Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis","volume":"8","author":"Echtenacher","year":"2002","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.bbi.2014.07.010_b0070","first-page":"187","article-title":"PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man","volume":"7","author":"Farde","year":"1996","journal-title":"Dementia"},{"key":"10.1016\/j.bbi.2014.07.010_b0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12031-002-0025-3","article-title":"AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer\u2019s disease","volume":"19","author":"Fisher","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2014.07.010_b0080","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/cc7710","article-title":"Inhibition of complement C5a prevents breakdown of the blood\u2013brain barrier and pituitary dysfunction in experimental sepsis","volume":"13","author":"Flierl","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbi.2014.07.010_b0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00019442-200201000-00010","article-title":"Brain proton magnetic resonance spectroscopy in Alzheimer disease: changes after treatment with xanomeline","volume":"10","author":"Frederick","year":"2002","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bbi.2014.07.010_b0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1566-0702(00)00219-8","article-title":"Vagal immune-to-brain communication: a visceral chemosensory pathway","volume":"85","author":"Goehler","year":"2000","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.bbi.2014.07.010_b0095","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1523\/JNEUROSCI.19-07-02799.1999","article-title":"Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?","volume":"19","author":"Goehler","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2014.07.010_b0100","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1073\/pnas.96.4.1692","article-title":"Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice","volume":"96","author":"Gomeza","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2014.07.010_b0105","doi-asserted-by":"crossref","first-page":"e15722","DOI":"10.1371\/journal.pone.0015722","article-title":"Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor","volume":"5","author":"Grant","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2014.07.010_b0110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jss.2007.07.021","article-title":"Injury of the blood brain barrier and up-regulation of Icam-1 in polymicrobial sepsis","volume":"146","author":"Hofer","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbi.2014.07.010_b0115","first-page":"2762","article-title":"Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis","volume":"35","author":"Huston","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0120","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20052362","article-title":"Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis","volume":"203","author":"Huston","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mi.2013.52","article-title":"Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis","volume":"7","author":"Ji","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bbi.2014.07.010_b0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/npp.2011.199","article-title":"Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia","volume":"37","author":"Jones","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2014.07.010_b0135","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.lfs.2012.05.006","article-title":"Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function","volume":"91","author":"Kawashima","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.bbi.2014.07.010_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2014.01.011","article-title":"Getting nervous about immunity","author":"Kelley","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbi.2014.07.010_b0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2011.08.056","article-title":"Behavioral effects of N-desmethylclozapine on locomotor activity and sensorimotor gating function in mice-possible involvement of muscarinic receptors","volume":"1418","author":"Maehara","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2014.07.010_b0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1242\/jeb.073411","article-title":"Immune-neural connections: how the immune system\u2019s response to infectious agents influences behavior","volume":"216","author":"McCusker","year":"2013","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.bbi.2014.07.010_b0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-642-25758-2_9","article-title":"Muscarinic mechanisms in psychotic disorders","author":"McKinzie","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbi.2014.07.010_b0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","article-title":"Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond","volume":"132","author":"Meyer","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbi.2014.07.010_b0165","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20132103","article-title":"Vagus nerve controls resolution and pro-resolving mediators of inflammation","volume":"211","author":"Mirakaj","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0170","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-065X.2012.01138.x","article-title":"Rethinking inflammation: neural circuits in the regulation of immunity","volume":"248","author":"Olofsson","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbi.2014.07.010_b0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2119\/2008-00079.Parrish","article-title":"Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling","volume":"14","author":"Parrish","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0180","first-page":"203","article-title":"Cholinergic modulation of inflammation","volume":"1","author":"Pavlov","year":"2008","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0185","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1073\/pnas.0600506103","article-title":"Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia","volume":"103","author":"Pavlov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2014.07.010_b0190","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/01.CCM.0000259381.56526.96","article-title":"Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis","volume":"35","author":"Pavlov","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","article-title":"Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway","volume":"23","author":"Pavlov","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.07.010_b0200","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1007\/s00018-004-4102-3","article-title":"Neural regulators of innate immune responses and inflammation","volume":"61","author":"Pavlov","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbi.2014.07.010_b0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbi.2005.03.015","article-title":"The cholinergic anti-inflammatory pathway","volume":"19","author":"Pavlov","year":"2005","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.07.010_b0210","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1042\/BST0341037","article-title":"Controlling inflammation: the cholinergic anti-inflammatory pathway","volume":"34","author":"Pavlov","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbi.2014.07.010_b0215","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrendo.2012.189","article-title":"The vagus nerve and the inflammatory reflex \u2013 linking immunity and metabolism","volume":"8","author":"Pavlov","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbi.2014.07.010_b0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF03402177","article-title":"The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation","volume":"9","author":"Pavlov","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2013.04.009","article-title":"Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias","volume":"31","author":"Raison","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2014.07.010_b0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nprot.2008.214","article-title":"Immunodesign of experimental sepsis by cecal ligation and puncture","volume":"4","author":"Rittirsch","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbi.2014.07.010_b0235","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0803237105","article-title":"Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia","volume":"105","author":"Rosas-Ballina","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2014.07.010_b0240","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1209985","article-title":"Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit","volume":"334","author":"Rosas-Ballina","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbi.2014.07.010_b0245","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.mad.2003.08.002","article-title":"Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis","volume":"124","author":"Saito","year":"2003","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbi.2014.07.010_b0250","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2119\/molmed.2011.00083","article-title":"Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice","volume":"17","author":"Satapathy","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3565(25)38667-2","article-title":"Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors","volume":"269","author":"Shannon","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2014.07.010_b0260","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","article-title":"Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia","volume":"165","author":"Shekhar","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2014.07.010_b0265","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1172\/JCI63493","article-title":"Lessons learned at the intersection of immunology and neuroscience","volume":"122","author":"Steinman","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2014.07.010_b0270","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4049\/jimmunol.0901808","article-title":"Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing gram-negative sepsis-induced acute lung inflammatory injury","volume":"184","author":"Su","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2014.07.010_b0275","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"Swirski","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbi.2014.07.010_b0280","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","article-title":"The inflammatory reflex","volume":"420","author":"Tracey","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2014.07.010_b0285","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI30555","article-title":"Physiology and immunology of the cholinergic antiinflammatory pathway","volume":"117","author":"Tracey","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2014.07.010_b0290","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nri2566","article-title":"Reflex control of immunity","volume":"9","author":"Tracey","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2014.07.010_b0295","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/SHK.0000000000000050","article-title":"High-mobility group box 1 mediates persistent splenocyte priming in sepsis survivors: evidence from a murine model","volume":"40","author":"Valdes-Ferrer","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.bbi.2014.07.010_b0300","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/joim.12104","article-title":"HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C(high) inflammatory monocytes in murine sepsis survivors","volume":"274","author":"Valdes-Ferrer","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbi.2014.07.010_b0305","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0140-6736(12)61815-7","article-title":"Sepsis definitions: time for change","volume":"381","author":"Vincent","year":"2013","journal-title":"Lancet"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114004024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114004024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:36:39Z","timestamp":1760168199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159114004024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":61,"alternative-id":["S0889159114004024"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2014.07.010","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2014.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}